title: Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care.
authors.affiliation: Rush University School of Medicine, Division of Rheumatology, Chicago, USA. tedpincus@gmail.com.
authors.forename: T
authors.initials: T
authors.lastname: Pincus
authors.forename: J
authors.initials: J
authors.lastname: Braun
authors.forename: A
authors.initials: A
authors.lastname: Kavanaugh
authors.forename: J S
authors.initials: JS
authors.lastname: Smolen
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000592:standards*; D019091:Critical Pathways / Q000592:standards*; D016208:Databases, Factual / Q000592:standards; D006801:Humans; D064887:Observational Studies as Topic / Q000592:standards*; D011237:Predictive Value of Tests; D012042:Registries / Q000592:standards; D012216:Rheumatic Diseases / Q000175:diagnosis* / Q000188:drug therapy*; D012219:Rheumatology / Q000592:standards*; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents